Myriad Genetics (MYGN): FQ2 EPS of $0.36 beats by $0.02. Revenue of $93M (+11%) vs. $91.6M....

|About: Myriad Genetics, Inc. (MYGN)|By:, SA News Editor
Myriad Genetics (MYGN): FQ2 EPS of $0.36 beats by $0.02. Revenue of $93M (+11%) vs. $91.6M. Shares +7% AH. (PR)